Cargando...
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
Elevated blood pressure (BP) is a major determinant of morbidity and mortality burden related to cardio‐metabolic risk. Current guidelines indicate that controlling and lowering BP promotes cardiovascular (CV) risk reduction. Among antihypertensive agents, angiotensin receptor blockers (ARBs) are ch...
Guardado en:
| Publicado en: | Cardiovasc Ther |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587798/ https://ncbi.nlm.nih.gov/pubmed/30358114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1755-5922.12471 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|